Bone Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 15, 2023 at 02:36 am IST
Bone Biologics Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 1.92 million compared to USD 1.22 million a year ago. Basic loss per share from continuing operations was USD 4.88 compared to USD 28.24 a year ago.
For the nine months, net loss was USD 7.4 million compared to USD 2.38 million a year ago. Basic loss per share from continuing operations was USD 37.44 compared to USD 55.12 a year ago.